Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children with Hematoplastic Disease
Latest Information Update: 04 Apr 2025
At a glance
- Drugs Bortezomib (Primary) ; Dasatinib (Primary) ; Eltrombopag (Primary) ; Imatinib (Primary) ; Pegaspargase (Primary) ; Pegfilgrastim (Primary)
- Indications Acute myeloid leukaemia; Haematological malignancies
- Focus Pharmacokinetics
Most Recent Events
- 30 Mar 2025 Planned End Date changed from 31 Dec 2021 to 31 Dec 2026.
- 30 Mar 2025 Planned primary completion date changed from 31 Dec 2021 to 31 Dec 2025.
- 12 Dec 2023 Results(n=26) presented at the 65th American Society of Hematology Annual Meeting and Exposition